Ocular Therapeutix, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $737.1M | $392.1M | $195.8M | $102.3M | $164.2M | $228.1M | $54.4M | $54.1M |
| Accounts Receivable | $30.7M | $32.4M | $26.2M | $21.3M | $21.1M | $12.3M | $2.5M | $201.0K |
| Inventory | $3.6M | $3.0M | $2.3M | $2.0M | $1.3M | $1.2M | $954.0K | $217.0K |
| Total Current Assets | $782.1M | $441.0M | $232.2M | $129.6M | $191.3M | $246.2M | $60.2M | $56.2M |
| Property, Plant & Equipment | $19.7M | $9.4M | $11.7M | $9.9M | $7.0M | $8.1M | $10.2M | $10.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $808.1M | $457.9M | $252.1M | $149.3M | $204.9M | $261.9M | $78.7M | $73.0M |
| Liabilities | ||||||||
| Accounts Payable | $4.2M | $4.2M | $4.4M | $5.1M | $4.6M | $2.7M | $3.3M | $3.0M |
| Total Current Liabilities | $50.8M | $41.4M | $34.9M | $31.4M | $26.3M | $26.7M | $12.0M | $9.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $153.7M | $142.6M | $160.9M | $113.9M | $116.9M | $185.8M | $82.4M | $37.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.16B | $-891.1M | $-697.6M | $-616.8M | $-545.8M | $-539.3M | $-383.6M | $-297.2M |
| Total Stockholders' Equity | $654.3M | $315.3M | $91.1M | $35.4M | $88.0M | $76.1M | $-3.6M | $35.9M |